Kite Pharma is a biopharmaceutical company dedicated to developing innovative cancer immunotherapies, with a primary focus on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies. Based in Santa Monica, CA, Kite aims to empower the immune system to recognize and eliminate tumors, striving for rapid and long-term durable responses while minimizing the burden of chronic care. The company is committed to scientific excellence and collaboration, fostering a diverse and inclusive work environment where every employee is valued and empowered to contribute to the mission of curing cancer.